RSS

commercialisation

Diagnostics company, Owlstone Medical, has raised $15 million to drive the global commercialisation of its Breath Biopsy platform. more

News

A three-year supply agreement has been entered into by Optibiotix, a life sciences company, and Galenicum Special Ingredients to commercialise products for health concerns such as high blood pressure and cholesterol. more

Technology

Array BioPharma and Pierre Fabre have announced a collaboration to globally develop and commercialise Array's late-stage novel oncology products, binimetinib and encorafenib more

News